Specific Cyt2 triggering increases CTLA-4 expression and decreases LAT phosphorylation. by Siobhan Ni Choileain (124123)

Mutations at S1/S2 site reduce SARS-CoV-2 S cleavage. by Prerna Arora (821926)

Casein kinase 1.2 depletion decreases ZC3H11 phosphorylation. by Igor Minia (399074)

“…Procyclic cells expressing in situ tagged V5-CK1.2, with a tetracycline-inducible stem-loop RNAi construct, were induced with tetracycline (200g/ml). …”

Six weeks of voluntary wheel running decreases 5-HT_2C mRNA expression in the medial dorsal striatum. by Benjamin N. Greenwood (295216)

Δ<i>ptsI</i> mutants are impaired for intramacrophage growth and virulence, with more decreased virulence in a Δ<i>glpD</i>/Δ<i>golD</i>/Δ<i>uhpT</i> background and can be trans-co... by Matthew J. Freeman (21094788)

Repeated dosing of P2Y13R agonist decreases HDL-C. by Marine Goffinet (90787)

The mitochondrial ROS-counteracting protein PRDX3 is decreased in NRF2i-DMA cells. by Bo-hyun Choi (630240)

Disruption of FGFR1-Frs2/3 pathway decreases the number of support cells. by Kazuya Ono (513633)

Exposure to low CO₂ levels decreases ER cholesterol levels. by Nityanand Bolshette (17396845)

“…<b>(B)</b> Bioluminescence recordings from the different conditions as depicted in <b>(A)</b>, the arrow indicates the time CO₂ was shifted from 5% to 1% (mean ± SE, <i>n</i> = 4 biological replicates per condition, AUC for 0 mM 0.34 ± 0.007, 1.59 ± 0.004 (<i>P</i> < 0.0001), 0.5 mM 1.00 ± 0.023, 2.68 ± 0.04 (<i>P</i> < 0.0001), 1 mM 1.66 ± 0.07, 3.34 ± 0.04 (<i>P</i> < 0.0001), 3 mM 2.06 ± 0.02, 2.79 ± 0.07 (<i>P</i> < 0.0001), 5 mM 2.02 ± 0.05, 2.43 ± 0.06 (<i>P</i> < 0.002), 7 mM 1.85 ± 0.01, 1.77 ± 0.02 (<i>P</i> < 0.02) two-sided Student’s <i>t</i> test). …”

PTB is associated with decreased spontaneous production of Type 1, 2, 17 and immunoregulatory cytokines. by Nathella Pavan Kumar (129299)

PF treatment decreases expressions of cytochrome c and Bax, but increases the expressions of Bcl-2. by Ruo-Bing Guo (298949)

Exposure to low CO₂ levels decreases ER cholesterol levels. by Nityanand Bolshette (17396845)

Effect of newborn anoxia on ET_A- and ET_B-receptor protein abundance in the neonatal heart. by Alexandra N. Paradis (693466)

Subjects:

The involvement of ERK5 in fluvastatin-induced Nrf2 signaling in VSMCs. by Ae-Rang Hwang (4040408)

Subjects:

The involvement of ERK5 in statin-induced Nrf2 signaling in VSMCs. by Ae-Rang Hwang (4040408)

Subjects:

The <i>P[syt^P-L]</i> mutation decreases the Ca²⁺ affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

“…Scale bar 2mV, 3s. (D) Paired-pulse analysis indicates a decrease in release probability in <i>+/-;P[syt^P-L]/+</i>. …”

Stimulation of α2-adrenergic receptors inhibits hippocampal precursor activity and decreases neurogenesis. by Dhanisha J. Jhaveri (577341)

“…<p>(A) Treatment of hippocampal precursor cells with α2-adrenergic receptor agonist at 10 uM significantly decreased neurosphere formation compared to the control. …”

A Y45F mutation in hepatitis C virus NS4A causes a decrease in infectious viral titer. by Allison E. Roder (6312761)

Increased apoptosis and decreased necrosis after BCL-W and BCL2 and autophagy inhibition. by Anatasha C. Crawford (255140)

Effect of CLK2 and SRPK1 KD in HBV-infected dHepaRG cells. by Florentin Pastor (19852287)